Therefore, our team hypothesized that targeted regulation of VEGF-C and CCR7 may become a novel therapeutic option for the prevention and treatment of brain metastasis via lymphatic route in patients with hepatocellular carcinoma in the future. This evidence concerns the gene CCR7 and hepatocellular carcinoma.